They have a lot of lawyers and don't make any claims that CS works for anything but disinfection of surfaces...except in other countries.
These people are masters of slippery language.
..looks like they're in the process of applying linguistic teflon again.
Ode

At 02:59 PM 2/27/2004 -0600, you wrote:
>>>>
Which begs the question: Why is the FDA not running this company out of business for advertising what CS can do?




----- Original Message -----
From: <mailto:[email protected]>Jan Stoeten
To: <mailto:[email protected]>[email protected]
Sent: Friday, February 27, 2004 10:22 AM
Subject: Re: CS>5 days for Malaria


<http://www.silversolution.us/>http://www.silversolution.us/

Jan Stoeten, the Netherlands
----- Original Message -----
From: <mailto:[email protected]>Medwith, Robert
To: <mailto:'[email protected]'>'[email protected]'
Sent: Friday, February 27, 2004 4:03 PM
Subject: RE: CS>5 days for Malaria


What is ASAP Solution are they talking about CS
Bob
-----Original Message-----
From: <mailto:[email protected]>[email protected] [mailto:[email protected]] On Behalf Of William Meyer
Sent: Friday, February 27, 2004 9:39 AM
To: <mailto:[email protected]>[email protected]
Subject: Re: CS>5 days for Malaria


what is notable here is that no mining company can profit from "homeopathic"


silver. so, this has nothing to do with mining profits. it is a different idea.


On Feb 27, 2004, at 8:25 AM, Ross Craig wrote:



Clifton Mining Company - New Human Study Data Released


ALPINE, UT, Feb. 27 /CNW/ - Clifton Mining Company (Clifton)(OTC:CFTN)

American Biotech Labs (a private company in which Clifton, the largest

shareholder is releasing new human study data on use of the ASAP Solution in

west African hospitals, against a number of human ailments including malaria

and a viral infections.



New Human Studies



American Biotech Labs (ABL) has been working in conjunction with four

hospitals in West Africa that have been conducting human studies of the ASAP

product as a antibiotic alternative against human ailments like malaria,

fungal infections, ear infections, measles, septic ulcers and a number of

serious viral problems. This is the second set of human studies released by

the west African hospitals. The new studies found the product effective

against all the above ailments. In conjunction with the human studies, the

country of Ghana has approved the ASAP supplement product as a homeopathic

drug.



Malaria



The past ASAP human malarial studies found the product effective in all

of the cases averaging only five days of treatment to full recovery. This new

study has taken the testing to a new level checking the blood of patients

deemed fully recovered to see if any signs of the parasites remain in the

bloodstream. According to the data in the studies, the patients showed

absolutely no malarial protozoans left in the bloodstream. Over 900 million

people are estimated to have this disease, many in poor countries. Said Keith

Moeller, VP, "Evidence is steadily mounting that we may be able to help

millions of people who are suffering from this disease. It is also exciting to

see the first human studies in which the product is being used as a treatment

for people who suffer from serious viral infections." Testing of the ASAP

product continues in the African hospitals, as well as in numerous other

facilities worldwide.

<<<<



-- The Silver List is a moderated forum for discussing Colloidal Silver.
Instructions for unsubscribing are posted at: http://silverlist.org
To post, address your message to: [email protected] Silver List archive: http://escribe.com/health/thesilverlist/index.html
Address Off-Topic messages to: [email protected] OT Archive: http://escribe.com/health/silverofftopiclist/index.html
List maintainer: Mike Devour <[email protected]>